Quantcast

Latest Sequenom Inc. Stories

2014-06-09 08:28:07

SAN DIEGO, June 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading health insurance company covering 13 million people throughout the United States, to provide the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives...

2014-06-04 12:29:57

Swiss Red Cross Study Recommends Replacing Kell, Kidd, Duffy Serotyping with Genotyping SAN DIEGO, June 4, 2014 /PRNewswire/ -- Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today, introduced the Hemo ID((TM) )Blood Group Genotyping Panel for the MassARRAY(®) System following a Swiss Red Cross study using a beta version of the panel published in the journal Transfusion. The study, which genotyped and serotyped more than 4,000 blood donors...

2014-05-30 16:25:09

SAN DIEGO, May 30, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it has completed the sale of its Bioscience business to Agena Bioscience, a portfolio company of Telegraph Hill Partners. The terms of the agreement provide for a purchase price of $31.8 million, subject to certain adjustments, and Sequenom may also receive up to $4 million in contingent consideration upon the...

2014-05-30 16:25:06

John Lillig to Lead Agena Bioscience as Chairman and Interim CEO SAN DIEGO, May 30, 2014 /PRNewswire/ -- Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc. (NASDAQ: SQNM), which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories. Agena Bioscience has retained the employees of the acquired segment and will remain headquartered in...

2014-05-27 12:32:06

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -...

2014-05-27 08:27:48

SAN DIEGO, May 27, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the Jefferies 2014 Global Healthcare Conference at the Grand Hyatt in New York, NY on June 2-3, 2014. William Welch, President and Chief Operating Officer, and Carolyn Beaver, Vice President and Chief Accounting Officer, will present on Tuesday, June 3, beginning at 2:00 p.m. ET to provide an...

2014-05-01 16:33:12

20% Year-Over-Year Increase in Total Revenues Led By Continued Growth in Diagnostic Services SAN DIEGO, May 1, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported record revenue of $46.3 million for the first quarter of 2014, an increase of 20% compared to revenue of $38.5 million for the first quarter of 2013. First quarter 2014 revenues from diagnostic services grew 27% compared to the first quarter of...

2014-04-17 08:27:51

SAN DIEGO, April 17, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the first quarter of 2014 after closing of the NASDAQ Global Market on Thursday, May 1, 2014. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EDT (2:00 pm...

2014-03-21 16:23:33

SAN DIEGO, March 21, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a resolution of litigation between the Company and Paul Hawran. Mr. Hawran served as the Company's Chief Financial Officer from April 2007 until September 2009. Mr. Hawran resigned in September 2009. After September 2009, the Securities and Exchange Commission conducted an investigation concerning...

2014-03-19 04:21:22

DUBLIN, March 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tdmwb8/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Report" [http://www.researchandmarkets.com/research/tdmwb8/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal testing is increasingly being adopted by high risk pregnant women for the...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related